on Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Protagonist Therapeutics to Attend Jefferies Global Healthcare Conference 2025
Protagonist Therapeutics, Inc., a biopharmaceutical company from Newark, CA, announced its participation in the Jefferies Global Healthcare Conference in New York, scheduled for June 3-5, 2025. CEO Dinesh V. Patel will present a company overview on June 4 at 1:25 P.M. ET. The company will also hold one-on-one meetings.
A webcast of the presentation will be available on Protagonist's Investor Relations web page for one year post-event. Those interested in meetings can contact their Jefferies representative.
Protagonist Therapeutics focuses on drug discovery and development. Their key projects include icotrokinra, developed with Johnson & Johnson, and rusfertide, in collaboration with Takeda Pharmaceuticals. Both are in Phase 3 clinical trials aiming for FDA submissions in 2025.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Protagonist Therapeutics, Inc. news